A detailed history of Fishman Jay A LTD transactions in Pfizer Inc stock. As of the latest transaction made, Fishman Jay A LTD holds 294,287 shares of PFE stock, worth $8.15 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
294,287
Previous 290,732 1.22%
Holding current value
$8.15 Million
Previous $8.37 Million 2.44%
% of portfolio
0.9%
Previous 0.96%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$25.89 - $29.73 $92,038 - $105,690
3,555 Added 1.22%
294,287 $8.17 Million
Q4 2023

Jan 24, 2024

BUY
$26.13 - $33.94 $14,371 - $18,667
550 Added 0.19%
290,732 $8.37 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $701,134 - $819,555
-21,849 Reduced 7.0%
290,182 $9.63 Million
Q2 2023

Aug 15, 2023

SELL
$36.12 - $41.79 $1.9 Million - $2.2 Million
-52,620 Reduced 14.43%
312,031 $11.4 Million
Q1 2023

May 09, 2023

SELL
$39.39 - $51.28 $1.02 Million - $1.33 Million
-25,853 Reduced 6.62%
364,651 $14.9 Million
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $442,174 - $577,209
-10,591 Reduced 2.64%
390,504 $20 Million
Q3 2022

Oct 26, 2022

BUY
$43.76 - $53.42 $122,134 - $149,095
2,791 Added 0.7%
401,095 $17.6 Million
Q2 2022

Aug 09, 2022

SELL
$46.53 - $55.17 $434,497 - $515,177
-9,338 Reduced 2.29%
398,304 $20.9 Million
Q1 2022

May 10, 2022

SELL
$45.75 - $56.69 $375,150 - $464,858
-8,200 Reduced 1.97%
407,642 $21.1 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $3.64 Million - $5.39 Million
88,065 Added 26.87%
415,842 $24.6 Million
Q3 2021

Nov 08, 2021

SELL
$39.25 - $50.42 $4.3 Million - $5.52 Million
-109,536 Reduced 25.05%
327,777 $14.1 Million
Q2 2021

Aug 09, 2021

SELL
$35.91 - $40.68 $940,051 - $1.06 Million
-26,178 Reduced 5.65%
437,313 $17.1 Million
Q1 2021

May 03, 2021

SELL
$33.49 - $37.77 $1.2 Million - $1.36 Million
-35,902 Reduced 7.19%
463,491 $16.8 Million
Q2 2020

Aug 10, 2020

SELL
$30.12 - $36.54 $371,229 - $450,355
-12,325 Reduced 2.41%
499,393 $15.5 Million
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $4.04 Million - $5.78 Million
-149,594 Reduced 22.62%
511,718 $15.8 Million
Q1 2020

May 12, 2020

BUY
$27.03 - $38.62 $2.76 Million - $3.95 Million
102,257 Added 18.29%
661,312 $20.5 Million
Q4 2019

Feb 04, 2020

SELL
$32.92 - $37.36 $1.22 Million - $1.39 Million
-37,090 Reduced 6.22%
559,055 $20.8 Million
Q3 2019

Nov 05, 2019

SELL
$32.49 - $42.13 $754,417 - $978,258
-23,220 Reduced 3.75%
596,145 $20.3 Million
Q2 2019

Aug 06, 2019

SELL
$36.98 - $41.52 $1.55 Million - $1.74 Million
-41,947 Reduced 6.34%
619,365 $0
Q1 2019

May 01, 2019

SELL
$37.5 - $41.2 $155,625 - $170,980
-4,150 Reduced 0.62%
661,312 $0
Q4 2018

Feb 05, 2019

SELL
$38.47 - $43.86 $287,755 - $328,072
-7,480 Reduced 1.11%
665,462 $27.6 Million
Q3 2018

Oct 31, 2018

SELL
$34.47 - $41.81 $137,880 - $167,240
-4,000 Reduced 0.59%
672,942 $0
Q2 2018

Aug 06, 2018

SELL
$32.98 - $35.16 $556,570 - $593,360
-16,876 Reduced 2.43%
676,942 $0
Q1 2018

May 08, 2018

SELL
$31.91 - $37.02 $369,198 - $428,321
-11,570 Reduced 1.64%
693,818 $0
Q4 2017

Feb 05, 2018

SELL
$33.26 - $35.29 $137,097 - $145,465
-4,122 Reduced 0.58%
705,388 $0
Q3 2017

Oct 31, 2017

BUY
$31.0 - $34.15 $22 Million - $24.2 Million
709,510
709,510 $0

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $155B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Fishman Jay A LTD Portfolio

Follow Fishman Jay A LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fishman Jay A LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fishman Jay A LTD with notifications on news.